A personalized blood test measuring circulating tumor DNA (ctDNA) can identify colorectal cancer patients who benefit most from adjuvant chemotherapy after liver metastasis surgery. According to the Phase II GALAXY study presented at the ESMO Gastrointestinal Cancers Congress 2026, patients with detectable ctDNA after surgery saw overall survival rates of 65% with chemotherapy, compared to … Read more
A blood test detecting circulating tumour DNA (ctDNA) after surgery can identify colorectal cancer patients most likely to benefit from adjuvant chemotherapy, according to research presented at the 2026 ESMO Gastrointestinal Cancers Congress. The Phase II GALAXY study, led by researchers from Hyogo Medical University and collaborators including the University of Oxford, found that patients … Read more
The Stockholm3 blood test identifies clinically significant prostate cancer more effectively than traditional Prostate-Specific Antigen (PSA) screening, according to a study published in the Annals of Internal Medicine. Researchers at Karolinska Institutet found the new test detected 90 percent of aggressive tumors compared to 74 percent for PSA, without increasing the rate of unnecessary follow-up … Read more
An ultrasensitive blood test called HPV-DeepSeek can identify residual cancer cells in patients following surgery for HPV-associated head and neck cancer, potentially enabling more personalized treatment plans. A study published in Science Translational Medicine by researchers at the Mass General Brigham Cancer Institute found the test detects circulating tumor HPV DNA with higher sensitivity than … Read more
A New Frontier in Early Detection: The Immuno-Infrared Sensor For years, the medical community has faced a daunting challenge: by the time symptoms of Alzheimer’s or Parkinson’s disease manifest, the brain has often suffered irreversible damage. Modern diagnostic approaches are largely symptom-oriented, which frequently delays essential intervention. However, a breakthrough in blood-based diagnostics may soon … Read more
The Alzheimer’s Blood Test Dilemma: Hope, Hype, and What It Means for You The promise is compelling: a simple blood test, administered even before symptoms appear, could reveal your future risk of developing Alzheimer’s disease. But as these tests become more readily available, a crucial question arises – should you acquire tested, and what would … Read more
Alzheimer’s Blood Tests: A New Era of Early Detection and Patient Empowerment For decades, the fear of Alzheimer’s disease has loomed large, often accompanied by uncertainty and delayed diagnoses. Now, a groundbreaking shift is underway, driven by the development of blood-based biomarker tests and a surprising willingness among patients to embrace them. A recent Northwestern … Read more
Prostate Cancer Screening: A New Era of Precision and Reduced Anxiety The landscape of prostate cancer screening is rapidly evolving, with advancements showcased at the European Association of Urology Congress (EAU26) in London. From increasingly accurate diagnostic tools to strategies for minimizing patient anxiety, the focus is shifting towards more personalized and effective care. The … Read more
The Future of Prediabetes Detection: How AI and Epigenetics are Rewriting the Risk Assessment For the 88 million American adults with prediabetes, the path to type 2 diabetes isn’t a foregone conclusion. But knowing which individuals are at highest risk – and therefore need the most aggressive intervention – has been a significant challenge. Now, … Read more
The Silent Threat: How Xylazine is Changing the Opioid Crisis – and What’s Next A concerning trend is unfolding across the United States, particularly in the Northeast: the increasing presence of xylazine, a powerful animal tranquilizer, in the illicit opioid supply. Recent research from the Icahn School of Medicine at Mount Sinai has pinpointed a … Read more